Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Cantón, , Urbano,
DOB: 01-APR-1945 (Age: 80)
Gender: male
Address:
Vial Vito Trujillo 29 Piso 2
38001 Santa Cruz de Tenerife (Spain)
ID: 8854-480268-4 (ECI)
Report
Date: 22-MAR-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Centro de Salud Ruiz de Padrón
(Spain)
Specimen
Collected: 22-MAR-2022

Chemistry

Test 22-MAR-2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.4 4.5 - 6.4 %
Cholesterol [Mass/volume] in Serum or Plasma 232.9 H 100 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 315.4 H 45 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 160.2 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 48.5 40 - 100 mg/dL
Glucose [Mass/volume] in Blood 93.2 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 11.2 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 2.8 H 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 101.2 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.1 L 22 - 29 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.4 6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.5 3.2 - 5.5 g/dL
Globulin [Mass/volume] in Serum by calculation 2.9 1.5 - 3.5 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 127.8 39 - 147 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 43.8 7 - 60 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35.5 10 - 40 U/L
Glucose [Mass/volume] in Blood 93.2 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 11.2 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.6 L 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 101.2 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.1 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 254.8 H 100 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 130.3 45 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 182.5 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 46.3 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 10.3 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated total cholesterol and triglycerides, indicating dyslipidemia, and mildly increased LDL. Creatinine results are inconsistent (one high, one low), but if elevated, may suggest impaired renal function. Total CO₂ is slightly low, possibly reflecting mild metabolic acidosis. Glucose and HbA1c are within normal limits. Liver function, electrolytes, and protein levels are unremarkable. Recommend clinical correlation for renal function and cardiovascular risk assessment, and consider repeat creatinine testing to clarify renal status.